Benner Joshua S, Cherry Spencer B, Erhardt Leif, Fernandes Michèle, Flammer Martina, Gaciong Zbigniew, Girerd Xavier, Johnson Eric S, García-Puig Juan, Sturkenboom Miriam C J M, Sun William
ValueMedics Research, LLC., Falls Church, VA 22046, USA.
Contemp Clin Trials. 2007 Sep;28(5):662-73. doi: 10.1016/j.cct.2007.03.004. Epub 2007 Mar 15.
To test the primary study hypothesis that a physician-delivered coronary heart disease risk evaluation and communication program can lower patients' predicted 10-year risk of myocardial infarction or death due to coronary heart disease by 10% within 6 months compared to usual care.
Prospective, parallel group, open-label, controlled, cluster-randomized multinational trial; the study site is the unit of randomization.
Patients were recruited from 106 general practices located in nine European countries.
Men and women aged 45 to 64 (N=1500) with a documented history of hypertension (treated or untreated), systolic blood pressure > or =140 mmHg (or > or =130 mmHg in the presence of renal or kidney disease), no history of cardiovascular disease, and a predicted 10-year risk of myocardial infarction or death due to coronary heart disease > or =10%.
Sites were randomized to deliver a physician-directed coronary heart disease risk communication and education program or usual care. The intervention program included informing patients of their 10-year risk of myocardial infarction or death due to coronary heart disease, educating patients about modifiable risk factors and their control, and three follow-up phone calls by a physician or study nurse.
Predicted 10-year risk of myocardial infarction or death due to coronary heart disease at 6 months.
REACH OUT will evaluate a novel, patient-focused, physician-implemented application of coronary heart disease risk equations. Results of the study will be of practical relevance to physicians, health care organizations, and those who issue clinical guidelines for the reduction of cardiovascular risk.
检验主要研究假设,即与常规护理相比,由医生提供的冠心病风险评估与沟通项目能够在6个月内将患者预测的10年心肌梗死或冠心病死亡风险降低10%。
前瞻性、平行组、开放标签、对照、整群随机化多国试验;研究地点为随机化单位。
患者从位于9个欧洲国家的106家普通诊所招募。
年龄在45至64岁之间的男性和女性(N = 1500),有高血压病史(无论是否接受治疗),收缩压≥140 mmHg(或在存在肾脏疾病时≥130 mmHg),无心血管疾病史,且预测的10年心肌梗死或冠心病死亡风险≥10%。
各研究地点被随机分配,以实施由医生指导的冠心病风险沟通与教育项目或常规护理。干预项目包括告知患者其10年心肌梗死或冠心病死亡风险,对患者进行可改变风险因素及其控制的教育,以及由医生或研究护士进行三次随访电话。
6个月时预测的10年心肌梗死或冠心病死亡风险。
“伸出援手”(REACH OUT)研究将评估一种新颖的、以患者为中心、由医生实施的冠心病风险方程应用。该研究结果将对医生、医疗保健机构以及制定降低心血管风险临床指南的人员具有实际意义。